Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29071819)

Published in Ann Lab Med on January 01, 2018

Authors

Eunyoung Lee1, Yangsoon Lee2

Author Affiliations

1: Department of Laboratory Medicine, Hanyang University of College of Medicine, Seoul, Korea.
2: Department of Laboratory Medicine, Hanyang University of College of Medicine, Seoul, Korea. yangsoon@hanyang.ac.kr.

Articles cited by this

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 7.26

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 4.06

Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review. JAMA (2016) 2.01

A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst (2012) 1.83

Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut (2012) 1.14

Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology (2014) 1.10

Similar fecal immunochemical test results in screening and referral colorectal cancer. World J Gastroenterol (2012) 0.86

Improving the reporting of evaluations of faecal immunochemical tests for haemoglobin: the FITTER standard and checklist. Eur J Cancer Prev (2015) 0.84

A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer. Gut (2016) 0.81

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer. Gut (2015) 0.81

Fecal Immunochemical Testing: A Sensitive and Sustainable Approach for Population Colorectal Cancer Screening? Gastroenterology (2016) 0.80